Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Black Diamond Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +15 vs. Q3 2025
- Shares held
- 37.9M
- −902.0K (−2.3%) vs. Q3 2025
- Total value
- $92.0M
- −$54.9M (−37.4%) vs. Q3 2025
- New holders
- 27
- 36 more added
- Sold out
- 12
- 25 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 1,630,173 | $3.96M | 0.01% | +1,149,050+238.8% | Added |
| Vanguard Group Inc | 2,188,857 | $5.32M | 0.00% | 00.0% | Unchanged |
| NEA Management Company, LLC | 4,448,757 | $10.8M | 0.55% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 10,606,599 | $25.8M | 0.02% | −137,508−1.3% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −2,070,209−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −307,070−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −64,521−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −27,800−100.0% | Sold out |
| Brown Wealth Management, LLC | 0 | $0 | 0.00% | −20,932−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −18,026−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −11,366−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,415−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −646−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |